Alessandro Dimasi

Dr. Alessandro Dimasi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
Andrea CitarellaAndrea Citarella
Andrea Citarella
ADAlessandro Dimasi
Alessandro Dimasi
DMDavide Moi
Davide Moi
DPDaniele Passarella
Daniele Passarella
Angela ScalaAngela Scala
Angela Scala
Nicola MICALENicola MICALE
Nicola MICALE
The main protease (Mpro) plays a pivotal role in the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is considered a highly conserved viral target. Disruption of the catalytic activity of Mpro produces a detrimental effect on the course of the infection, making this target one of the most attractive for the treatment of COVID-19. The current success of the SARS-CoV-2 Mpro inhibitor Nirmatrelvir, the first oral drug for the treatment of severe forms of COVID-19, has further focused the attention of researchers on this important viral target, making the search for new Mpro inhibitors a thriving and exciting field for the development of antiviral drugs active against SARS-CoV-2 and related coronaviruses.

2 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Andrea CitarellaAndrea Citarella
Andrea Citarella
ADAlessandro Dimasi
Alessandro Dimasi
DMDavide Moi
Davide Moi
DPDaniele Passarella
Daniele Passarella
Angela ScalaAngela Scala
Angela Scala
Nicola MICALENicola MICALE
Nicola MICALE
The Main Protease (Mpro) plays a pivotal role in the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is considered a highly conserved viral target. Disruption of the catalytic activity of Mpro produces a detrimental effect on the course of the infection, making this target one of the most attractive for the treatment of COVID-19. The current success of the SARS-CoV-2 Mpro inhibitor Nirmatrelvir, the first oral drug for the treatment of severe forms of COVID-19, has further focused the attention of researchers on this important viral target, making the search for new Mpro inhibitors a thriving and exciting field for the development of antiviral drugs active against SARS-CoV-2 and related coronaviruses.

9 October 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
AMArianna Montoli
Arianna Montoli
ADAlessandro Dimasi
Alessandro Dimasi
Andrea CitarellaAndrea Citarella
Andrea Citarella
PRPaolo Ronchi
Paolo Ronchi
DPDaniele Passarella
Daniele Passarella
VFValerio Fasano
Valerio Fasano
Replacing hydrogen with deuterium raises the activation energy for C‒D bond cleavage. This approach has gained attention in drug design, especially to protect the ortho-position of pyridines, which are susceptible to enzymatic oxidation. Until now, direct hydrogen isotope exchange has been largely restricted to the use of reactive organolithium reagents or metal-catalysed deuteration methods. In this work, we present a metal-free, selective ortho-deuteration of N-heterocycles starting from their N-oxides, proceeding at room temperature in just 5 minutes. This method achieves high deuterium incorporation across a broad range of N-heterocycles, including bioactive compounds. Experimental and computational studies have elucidated the mechanism of the reaction, showing that regioselectivity is driven by a successful increase in acidity at the ortho-position, enabling deprotonation by the in-situ generated dimsyl anion.

8 October 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
AMArianna Montoli
Arianna Montoli
ADAlessandro Dimasi
Alessandro Dimasi
MGMiriana Guarnaccia
Miriana Guarnaccia
Andrea CitarellaAndrea Citarella
Andrea Citarella
PRPaolo Ronchi
Paolo Ronchi
VFValerio Fasano
Valerio Fasano
Pyridines can be deuterated at remote sites by treatment with KOtBu in DMSO-d6, although without discrimination between the meta- and para-position. Herein, base-catalyzed deuterations have been studied, computationally and experimentally, on a series of pyridyl phosphonium and ammonium salts having a temporary electron-withdrawing group to block the para-position while increasing the acidity in the other positions.